Hantavirus Cruise Ship Outbreak: MV Hondius Andes Virus Cases, Symptoms and Public Risk Explained

A rare hantavirus cruise ship outbreak linked to the MV Hondius has become an international public-health concern after passengers developed severe respiratory illness caused by Andes virus, a type of hantavirus associated with hantavirus pulmonary syndrome. WHO reported a multi-country hantavirus cluster linked to cruise ship travel involving the MV Hondius, with 11 cases and 3 deaths as of 13 May 2026 [1]. ECDC also reported 11 cases, including 8 confirmed, 2 probable and 1 inconclusive case, and identified the virus as Andes hantavirus [2].

Table : Latest MV Hondius Hantavirus Outbreak Snapshot

The outbreak was first reported to WHO on 2 May 2026, after a cluster of severe acute respiratory illness was detected aboard the Dutch-flagged MV Hondius [1]. CDC later confirmed that the outbreak was caused by Andes virus, which can lead to hantavirus pulmonary syndrome, a severe and potentially fatal lung disease [3,4]. Unlike common cruise illnesses such as norovirus, this cruise ship virus outbreak is unusual because Andes virus is the only hantavirus known to have documented person-to-person transmission, although this usually requires close or prolonged contact [4,8,13].

Health agencies have stressed that the outbreak is serious for exposed passengers and close contacts, but not a reason for public panic. WHO assessed the global public-health risk as low, ECDC assessed the risk to the EU/EEA general population as very low, and CDC stated that the overall risk to the American public and travelers remains extremely low [1,2,3]. This distinction is important: Andes virus can cause severe disease, but it does not spread easily in the community like COVID-19 [1,3,13].

The reason the MV Hondius hantavirus outbreak is newsworthy is not only the number of deaths, but also the rare combination of cruise travel, severe respiratory illness, possible onboard transmission, and international passenger movement. WHO’s current working hypothesis suggests that the first case may have acquired infection before boarding, possibly through land-based exposure, with later evidence suggesting subsequent human-to-human transmission onboard the ship [1]. This means the outbreak should not automatically be interpreted as proof of rodent infestation on the ship; investigations are still examining the original source and exposure chain [1,4].

Travelers should watch carefully for Andes virus symptoms, especially after relevant exposure. CDC states that symptoms of hantavirus pulmonary syndrome due to Andes virus may appear 4 to 42 days after exposure and can begin with fever, fatigue, muscle aches, headache, dizziness, chills, nausea, vomiting, diarrhea or abdominal pain [8]. Later symptoms may include cough, chest tightness and shortness of breath, which require urgent medical evaluation [8,13].

At present, there is no authorized antiviral treatment or vaccine for hantavirus infection. EMA states that clinical management relies on supportive care and timely access to critical-care facilities [15]. Therefore, any passenger or close contact with fever followed by breathing difficulty should seek emergency care and clearly mention cruise travel, MV Hondius exposure, South America travel, rodent exposure, or contact with a suspected Andes virus case [4,8,15].

Latest update: WHO reported 11 cases and 3 deaths in a multi-country hantavirus cluster linked to cruise ship travel involving the MV Hondius as of 13 May 2026 [1]. The virus has been identified as Andes virus, a hantavirus that can cause severe lung disease and rarely spread between people after close or prolonged contact [2,3,8]. Health agencies currently describe the wider public risk as low or extremely low [1,2,3].

Latest Outbreak Snapshot: MV Hondius Hantavirus Outbreak

As of 13 May 2026, WHO reported 11 cases, including 3 deaths, in a multi-country hantavirus cruise ship outbreak linked to the MV Hondius [1]. ECDC listed the outbreak as 8 confirmed cases, 2 probable cases and 1 inconclusive case, with 3 deaths reported in total [2]. The virus involved has been identified as Andes virus, a hantavirus that can cause hantavirus pulmonary syndrome, a severe respiratory illness that may become life-threatening in some patients [1,2,3].

The MV Hondius arrived at Granadilla, Tenerife, on 10 May 2026, and ECDC reported that disembarkation of passengers and part of the crew was completed on 11 May 2026 [2]. Repatriation of passengers and crew members to their respective countries was also reported as completed, while exposed contacts remained under public-health follow-up, monitoring and testing according to national guidance [2,7].

Although the MV Hondius hantavirus outbreak is serious because of the deaths and the severity of hantavirus pulmonary syndrome, official agencies have emphasized that the risk to the wider public remains low. WHO assessed the global public-health risk as low, while CDC stated that the overall risk to the public and travelers remains extremely low [1,3]. The main concern is for passengers, crew members and close contacts who may have had relevant exposure during the cruise or close contact with a suspected or confirmed Andes virus case [1,2,7].

What Happened on the MV Hondius?

The MV Hondius hantavirus outbreak came to international attention after a cluster of severe respiratory illness was identified among passengers who had travelled on the Dutch-flagged expedition cruise ship MV Hondius. WHO was notified on 2 May 2026 of a multi-country hantavirus cruise ship outbreak linked to cruise ship travel, and later official updates identified the virus involved as Andes virus, a hantavirus that can cause hantavirus pulmonary syndrome [1,2,4].

The outbreak became newsworthy because it involved severe illness, international passengers, multiple deaths and a rare virus that is not usually associated with cruise ship outbreaks. Unlike common cruise infections such as norovirus, Andes virus can cause serious lung disease and, in rare situations, may spread from one person to another after close or prolonged contact [1,2,4]. This made the event medically important even though health agencies continued to describe the wider public risk as low or extremely low [1,3].

CDC described the cruise as linked to travel that began from Ushuaia, Argentina, with passengers later moving across international routes [4]. Some affected passengers developed severe respiratory disease, including symptoms consistent with hantavirus pulmonary syndrome, which can progress rapidly and require urgent hospital care [4,8,13]. As the cluster grew, public-health agencies began contact tracing, case investigation, testing, disembarkation planning and international coordination for passengers and crew [1,2,5,6,7].

An important point is that the outbreak should not automatically be understood as proof that the cruise ship itself was the original source of infection. WHO’s working hypothesis suggests that the first case may have acquired Andes virus before boarding, possibly through land-based exposure, followed by possible human-to-human transmission onboard the ship [1]. This means the MV Hondius hantavirus outbreak is better understood as a complex travel-associated Andes virus outbreak rather than a simple ship sanitation incident.

After the ship reached Granadilla, Tenerife, on 10 May 2026, disembarkation of passengers and part of the crew was completed on 11 May 2026, followed by repatriation and monitoring of exposed contacts according to national public-health guidance [2,7]. Because Andes virus symptoms may appear days to weeks after exposure, passengers and close contacts required continued follow-up even after leaving the ship [6,7,8]. This prolonged monitoring was necessary to detect new symptoms early, reduce further transmission risk and ensure rapid medical care for anyone who developed fever, cough, breathlessness or other warning signs of hantavirus pulmonary syndrome [6,7,8].

Timeline of the Hantavirus Cruise Ship Outbreak

The MV Hondius hantavirus outbreak began as a cluster of severe respiratory illness among passengers and crew during a South Atlantic cruise. According to CDC, the cruise had departed from Ushuaia, Argentina, before travelling through remote regions, including areas where environmental exposure to rodents may occur [4]. On 2 May 2026, WHO was notified of a cluster of severe acute respiratory illness aboard the ship, and further laboratory investigation later confirmed that the virus involved was Andes virus [1,4].

Early official reports described a small but severe cluster, including deaths and critically ill passengers [4]. As investigations progressed, WHO reported 11 cases, including 3 deaths, as of 13 May 2026 [1]. ECDC later categorized the cases as 8 confirmed, 2 probable and 1 inconclusive, showing that the outbreak was being assessed through laboratory confirmation, clinical findings and epidemiological links [2].

The ship arrived at Granadilla, Tenerife, on 10 May 2026, and disembarkation of passengers and part of the crew was completed on 11 May 2026 [2]. Public-health authorities then coordinated repatriation, contact tracing, testing and monitoring for exposed individuals [2,7]. This international response was necessary because passengers and crew came from multiple countries, and Andes virus can have a long incubation period before symptoms appear [1,7,8].

What Is Hantavirus?

Hantaviruses are a group of viruses that are mainly associated with rodents. People usually become infected after exposure to urine, droppings or saliva from infected rodents, especially when contaminated dust is inhaled in enclosed or poorly ventilated spaces [8,13]. Hantavirus infection is uncommon, but it can become severe when it affects the lungs or kidneys [13].

In the Americas, some hantaviruses can cause hantavirus pulmonary syndrome, also called hantavirus cardiopulmonary syndrome, which is a serious illness involving the lungs and circulation [13]. In Europe and Asia, other hantaviruses are more commonly associated with hemorrhagic fever with renal syndrome, where kidney involvement may be more prominent [13]. The MV Hondius hantavirus outbreak is especially important because the virus identified was Andes virus, which is linked to severe lung disease and has rare documented person-to-person transmission [1,8,13].

Hantavirus pulmonary syndrome usually begins with non-specific symptoms that can resemble influenza or another viral illness. The disease can then progress to cough, chest tightness, shortness of breath, fluid in the lungs and shock [8,13]. This is why a fever after relevant travel or exposure should not be ignored, especially if breathing symptoms develop later [8,13].

What Is Andes Virus?

Andes virus is a type of hantavirus found mainly in parts of South America. It is medically important because it can cause hantavirus pulmonary syndrome, a severe respiratory illness that may become fatal in some patients [8,13]. In the MV Hondius hantavirus outbreak, official agencies identified the virus as Andes virus, which explains why the outbreak received urgent international attention [1,2,3].

Most hantaviruses do not spread from person to person. Andes virus is the major exception, because limited human-to-human transmission has been documented, usually after close or prolonged contact with an infected person [8,13]. This does not mean that Andes virus spreads easily like COVID-19, influenza or measles. It means that close contacts, cabinmates, caregivers, intimate partners and people exposed to body fluids may require monitoring after contact with a confirmed or suspected case [6,8,13].

CDC states that Andes virus symptoms may appear 4 to 42 days after exposure [8]. This long incubation period is one reason why exposed passengers and crew may continue to be monitored after disembarkation and repatriation [6,7,8]. A person may feel well at the time of travel and still need follow-up if they had relevant exposure during the risk window [6,7,8].

Table : Hantavirus vs Andes Virus

Why This Outbreak Is Different From Norovirus, Flu or COVID-19

Cruise ship outbreaks are often associated with norovirus, influenza, COVID-19 or other respiratory and gastrointestinal infections. The MV Hondius outbreak is different because it involved Andes virus, a rare hantavirus that can cause severe pulmonary disease [1,2,3]. Unlike norovirus, which commonly causes vomiting and diarrhea and spreads easily through contaminated surfaces or food, Andes virus is not a typical cruise-ship infection [8,13].

The outbreak is also different from COVID-19 because Andes virus does not spread efficiently through casual community contact [1,3,8]. Health agencies have continued to describe the wider public risk as low or extremely low, even while treating the outbreak as serious for exposed passengers, crew and close contacts [1,2,3]. This distinction is important for public communication: the outbreak is severe, but it is not currently considered a pandemic-type threat [1,3].

The reason doctors are concerned is that hantavirus pulmonary syndrome can deteriorate rapidly once lung symptoms begin [8,13]. A patient may first experience fever, fatigue, muscle pain and gastrointestinal symptoms, then later develop cough, chest tightness and shortness of breath [8]. This pattern makes early recognition difficult, but delay in hospital care can be dangerous once respiratory symptoms appear [8,13].

Did the Infection Come From Rodents on the Ship?

One of the most important points is that the MV Hondius hantavirus outbreak should not automatically be blamed on rodents onboard the ship. WHO’s working hypothesis suggests that the first case may have acquired infection before boarding, possibly through land-based exposure, followed by possible human-to-human transmission onboard [1]. This means the outbreak may have started outside the cruise environment and then became a ship-associated event because of close contact during travel [1].

This distinction matters because hantavirus is usually linked to rodent exposure, but Andes virus has the additional unusual feature of possible person-to-person spread [8,13]. A traveler may have been exposed during land travel, rural lodging, outdoor activity, storage-area exposure or contact with contaminated dust before joining the cruise [1,4,8]. Once onboard, close or prolonged exposure to an infected person may have created risk for other passengers or crew [1,6,8].

Therefore, the accurate message is not simply “rodents on a cruise ship.” The better explanation is that this was a complex travel-associated Andes virus outbreak involving possible land exposure, severe respiratory illness and close-contact risk during cruise travel [1,2,4]. Public-health investigations are important because they help identify whether transmission occurred before boarding, during the voyage, or through a combination of exposures [1,2,6].

How Hantavirus Spreads

Most hantavirus infections occur when people inhale tiny particles contaminated by urine, droppings or saliva from infected rodents [8,13]. This may happen when a person sweeps, vacuums or disturbs rodent-contaminated dust in cabins, sheds, storage rooms, rural buildings or poorly ventilated spaces [11,13]. Infection can also occur through direct contact with contaminated materials, especially if the virus reaches the nose, mouth, eyes or broken skin [8,13].

Andes virus has an additional risk pattern because it can rarely spread between people [8,13]. Close or prolonged contact appears to be the main concern, rather than brief casual contact [6,8]. Risk may be higher for people who share a cabin, provide care to a sick person, have intimate contact, share utensils or drinks, handle contaminated bedding or clothing, or have unprotected exposure to body fluids [6,8,9].

For the general public, this means casual travel near a cruise passenger is not the main concern. The greater concern is relevant exposure history, such as being on the MV Hondius during the risk period, having close contact with a confirmed or suspected case, or having possible rodent exposure during travel in an affected region [1,6,8]. This is why health agencies focus on contact tracing and monitoring rather than broad public restrictions [1,2,6].

Why This Is Not “The Next COVID”

The MV Hondius hantavirus outbreak has received global attention because it involved deaths, international travel and a rare virus. However, official agencies have not described it as a COVID-like threat [1,2,3]. CDC stated that the risk of a pandemic from this outbreak and the overall risk to the public and travelers remains extremely low [3]. WHO also assessed the global public-health risk as low [1].

The main reason is that Andes virus does not spread easily through casual respiratory contact in the way that COVID-19 can [3,8,13]. Andes virus transmission is usually linked to rodent exposure, and person-to-person transmission is rare and generally associated with close or prolonged exposure [6,8,13]. This makes the outbreak serious for exposed contacts, but not a broad threat to people who had no relevant exposure [1,3,6].

At the same time, “low public risk” does not mean “no danger.” For a person who was exposed, Andes virus can cause severe disease and may require urgent medical care [8,13]. The correct public-health message is balanced: the general population should not panic, but passengers, crew and close contacts should follow monitoring, testing and isolation instructions carefully [1,2,6,7].

Incubation Period: Why Monitoring Can Last Weeks

The incubation period is one of the hidden reasons this outbreak requires prolonged follow-up. CDC states that symptoms of Andes virus infection may appear 4 to 42 days after exposure [8]. This means a person can feel healthy for days or weeks after contact and still remain within the risk window [8].

For this reason, exposed passengers and crew may be asked to monitor their temperature, watch for symptoms and remain in communication with public-health authorities [6,7,8]. UKHSA reported monitoring, testing and isolation support for people linked to the outbreak, reflecting the need to detect illness early and reduce the chance of further transmission [7]. A negative test early in the monitoring period may not always end follow-up if the person remains within the incubation window [6,7,8].

This long incubation period also explains why additional cases can sometimes appear after passengers have left the ship [1,2,8]. Such delayed detection does not automatically mean community spread. It may simply reflect the biology of Andes virus and the time it takes for symptoms to develop after exposure [6,8].

Symptoms of Andes Virus Infection

Andes virus infection can begin like many other viral illnesses. Early symptoms may include fever, fatigue, muscle aches, headache, dizziness, chills, nausea, vomiting, diarrhea and abdominal pain [8]. Because these symptoms are non-specific, a person may initially think they have influenza, food poisoning, COVID-19, dengue, another travel infection or a common viral fever [8,13].

The dangerous stage begins when respiratory symptoms appear. CDC describes later symptoms of hantavirus pulmonary syndrome as cough, chest tightness and shortness of breath, which may occur as the lungs fill with fluid [8]. This stage can progress quickly and may require hospital care, oxygen support or intensive care [8,13,15].

Any person who travelled on the MV Hondius, had close contact with a suspected or confirmed case, or had possible rodent exposure during recent travel should take fever and breathing symptoms seriously [1,4,8]. The most important instruction for patients is to tell the doctor about the travel and exposure history immediately, because hantavirus pulmonary syndrome may not be suspected unless the clinician knows the background [4,8,13].

Emergency Warning Signs

A person with possible Andes virus exposure should seek urgent medical care if fever is followed by cough, chest tightness, shortness of breath, severe weakness, fainting, confusion or bluish lips [8,13]. Breathlessness after a flu-like illness is especially important because hantavirus pulmonary syndrome can worsen rapidly once the lungs are involved [8,13].

Patients should not wait at home if breathing difficulty develops after relevant cruise travel or close contact with a suspected case [8,13]. They should tell emergency staff that they may have been exposed to Andes virus or were connected to the MV Hondius hantavirus outbreak [1,4,8]. This information helps doctors arrange appropriate testing, infection-control measures and critical care if needed [4,8,10].

Self-medication, home remedies or delayed consultation can be dangerous in suspected hantavirus pulmonary syndrome [8,13,15]. At present, management depends on early recognition and supportive hospital care, especially oxygen support and intensive monitoring when respiratory or circulatory symptoms develop [8,13,15].

Why Hantavirus Can Become Dangerous Quickly

Hantavirus pulmonary syndrome can become life-threatening because the infection affects the lungs and blood vessels [8,13]. In severe cases, fluid can leak into the lungs, making it difficult for oxygen to pass into the blood [8,13]. This can lead to shortness of breath, low oxygen levels, shock and the need for intensive care [8,13,15].

The frightening feature of hantavirus pulmonary syndrome is that the early phase may look like a routine viral fever, while the later phase can deteriorate quickly [8,13]. A patient may move from fever and body aches to breathing difficulty within a short period once the pulmonary phase begins [8]. This is why doctors pay close attention to travel history, exposure history and the timing of symptoms [4,8,10].

The deaths reported in the MV Hondius outbreak show why the cluster was taken seriously by WHO, ECDC, CDC and national health agencies [1,2,3]. Even though the public risk is low, the disease can be severe for individuals who become infected [1,3,8]. Public-health monitoring is therefore designed to identify symptoms early, guide testing and ensure that patients reach appropriate care before severe respiratory failure develops [1,6,7,8].

How Doctors Diagnose Hantavirus

Doctors diagnose suspected hantavirus infection by combining clinical symptoms, exposure history and laboratory testing [8,10,13]. The history is especially important because early symptoms can resemble influenza, COVID-19, dengue, leptospirosis, bacterial pneumonia or other travel-related infections [4,8,10]. A patient who does not mention cruise travel, South America travel, rodent exposure or contact with a suspected case may be harder to diagnose early [4,8,10].

Testing may include serology to detect immune response and molecular testing to detect viral genetic material, depending on timing and availability [10,13]. Doctors may also use oxygen saturation monitoring, chest imaging, blood tests and clinical assessment to determine whether the lungs or circulation are becoming affected [10,13]. Public-health authorities may become involved because confirmed or probable Andes virus cases require investigation and contact management [1,6,10].

In the MV Hondius hantavirus outbreak, diagnosis also depends on epidemiological links. This means doctors and public-health teams consider whether the person travelled on the ship, had close contact with a confirmed or probable case, or had exposure to environments where rodent contamination may have occurred [1,4,6,8]. This approach helps separate unrelated respiratory infections from possible outbreak-linked Andes virus infection [1,6,10].

Treatment and ICU Care

There is currently no authorized specific antiviral treatment or vaccine for Andes virus infection [8,13,15]. EMA stated that clinical management relies on supportive care and timely access to critical-care facilities [15]. This means treatment focuses on helping the body through the dangerous phase of illness, especially when breathing or circulation is affected [13,15].

Supportive care may include oxygen therapy, careful fluid management, monitoring of blood pressure, respiratory support and intensive care when needed [10,13,15]. In severe hantavirus pulmonary syndrome, patients may require advanced support because the lungs can fill with fluid and oxygen levels can fall rapidly [8,10,13]. Early transfer to a hospital with critical-care capacity can be life-saving for patients who begin to deteriorate [10,13,15].

The absence of a specific cure makes early medical evaluation even more important [8,15]. A patient with possible exposure should not wait for symptoms to become severe before seeking care. Fever with new cough, chest tightness or shortness of breath after relevant exposure should be treated as urgent [8,10,13].

Cruise Travel Safety Advice

The MV Hondius hantavirus outbreak does not mean that all cruise travel is unsafe [1,3]. CDC continues to describe the overall risk to travelers as extremely low [3]. However, passengers should understand how to reduce risk during cruise travel, especially when visiting remote areas, rural locations or regions where rodent-borne infections may occur [8,12,13].

Travelers should avoid contact with rodents, rodent droppings, nesting materials and dusty enclosed spaces where rodents may have been present [8,11,13]. They should also avoid handling dead rodents or cleaning contaminated spaces without proper precautions [11,13]. If rodent contamination is suspected in a cabin, lodging area or storage space, it should be reported to responsible staff rather than cleaned casually by the traveler [11,13].

During an outbreak situation, passengers should also avoid close contact with anyone who has fever, severe body aches, cough or breathing difficulty [6,8,9]. Sharing drinks, utensils, cigarettes, vapes, bedding or personal items with a symptomatic person should be avoided [6,8,9]. Anyone who develops fever or respiratory symptoms during a cruise should report promptly to the ship medical center and provide a clear travel and exposure history [4,8,12].

Safe Rodent Cleanup

Rodent cleanup is an important prevention topic because hantavirus can spread when contaminated dust becomes airborne [11,13]. CDC advises that rodent droppings, urine or nesting material should not be swept or vacuumed while dry, because this may release contaminated particles into the air [11]. Instead, contaminated material should be wetted with disinfectant before removal, and gloves should be used during cleanup [11].

The safest approach is to ventilate the area, avoid stirring up dust, apply disinfectant, allow enough contact time, wipe up the material carefully and dispose of it safely [11]. Hands should be washed thoroughly after removing gloves [11]. These steps are especially important in cabins, rural buildings, storage rooms, sheds, campsites and other enclosed spaces where rodents may have been present [11,13].

This advice applies broadly to hantavirus prevention and should not be used to claim that rodent contamination on the MV Hondius was proven [1,11]. WHO’s working hypothesis indicates possible land-based exposure before boarding, followed by possible human-to-human transmission onboard [1]. Still, safe rodent-cleanup education remains useful because rodent exposure is the usual route for hantavirus infection [8,11,13].

Public Health Response and Contact Tracing

The public-health response to the MV Hondius hantavirus outbreak involved international coordination because the ship carried passengers and crew from multiple countries [1,2,4]. WHO described measures including investigation, isolation, clinical management, medical evacuation, laboratory testing, contact tracing, quarantine and monitoring [1]. ECDC also reported disembarkation, repatriation and ongoing assessment of risk for affected countries [2].

Contact tracing is essential because Andes virus can rarely spread between people after close or prolonged contact [6,8,13]. Public-health teams work to identify people who may have shared cabins, provided care, had intimate contact, handled contaminated personal items or had other high-risk exposure to a confirmed or probable case [6]. These contacts may be monitored for fever and other symptoms during the incubation period [6,7,8].

Repatriation does not end public-health responsibility [2,7]. Once passengers return to their countries, national health agencies may continue symptom checks, testing, isolation support and instructions for what to do if illness develops [6,7]. This follow-up is necessary because symptoms may appear weeks after exposure [8].

High-Risk and Low-Risk Contacts

Not every person near the outbreak has the same level of risk [6,8]. A high-risk contact is more likely to be someone who had close, prolonged or direct exposure to a confirmed or probable Andes virus case [6]. This may include a cabinmate, caregiver, intimate partner, healthcare worker without appropriate protection, or someone who handled contaminated bedding, clothing, waste or body fluids [6,8,9].

A lower-risk contact may include a person who was in the same broader travel setting but did not have direct or prolonged close interaction with a case [6]. Public-health teams use this distinction to decide who needs closer monitoring, isolation, testing or movement restrictions [6,7]. This risk-based approach helps protect the public without creating unnecessary panic among people who had no meaningful exposure [1,3,6].

For readers, the practical message is simple: risk depends on exposure. A person who was not on the ship, did not have contact with an infected passenger and did not have rodent exposure is unlikely to be at risk [1,3,8]. A person who was on the ship or had close contact with a suspected case should follow official public-health instructions even if they currently feel well [6,7,8].

Myths and Misinformation

A major risk during rare outbreaks is misinformation. The MV Hondius hantavirus outbreak should not be described as a new COVID-19, a routine cruise stomach bug or proof of a confirmed shipwide rodent infestation [1,3,8]. Each of these claims oversimplifies the situation and can mislead readers.

EMA specifically warned against misinformation falsely linking hantavirus infection to COVID-19 vaccination [15]. There is no scientific basis for telling readers that the outbreak was caused by vaccination [15]. The official explanation is that the outbreak involved Andes virus, a hantavirus associated with rodent exposure and rare close-contact human transmission [1,8,13].

Another myth is that every cruise passenger worldwide is now at high risk. Official agencies have stated the opposite: the wider public risk remains low or extremely low [1,2,3]. The real concern is for exposed passengers, crew and close contacts linked to the MV Hondius outbreak, especially those who develop fever or respiratory symptoms during the incubation period [1,6,7,8].

Ayurvedic Perspective: Janapadodhwamsa, Ojas and Recovery

In Ayurveda, widespread illness affecting many people is discussed under the concept of Janapadodhwamsa in Charaka Samhita, Vimanasthana, Chapter 3 [28]. This classical idea describes how disturbance in shared environmental factors such as air, water, land and season can contribute to illness affecting communities [28]. In a modern article, this concept may be used as a public-health reflection, but it should not be presented as a virological explanation for Andes virus.

The MV Hondius hantavirus outbreak must be understood medically as an Andes virus outbreak requiring modern diagnosis, infection-control measures and emergency care when symptoms become severe [1,8,13,15]. Suspected hantavirus pulmonary syndrome is not a condition for home treatment or delayed consultation [8,13]. Fever followed by breathlessness after relevant exposure requires urgent medical evaluation [8,10,13].

Ayurvedic discussion may be appropriate only as supportive guidance after medical stabilization. The focus can be on recovery, nutrition, sleep, digestive strength, gradual rebuilding of strength, mental reassurance and protection of Ojas after severe illness [28,29]. This should be framed as convalescent support under qualified supervision, not as a substitute for hospital care, oxygen therapy or intensive treatment in acute hantavirus pulmonary syndrome [8,13,15].

What Travelers Should Tell Doctors

A person with possible exposure should clearly tell the doctor about recent cruise travel, especially any connection to the MV Hondius, South Atlantic travel, South America travel, contact with a sick passenger, rodent exposure or stay in rural environments [1,4,8]. This information can change the doctor’s level of suspicion and help guide testing [4,8,10].

A useful sentence for patients is: “I may have been exposed to Andes virus during recent cruise or travel activity, and I now have fever with respiratory or flu-like symptoms.” This kind of clear statement helps emergency staff identify the need for infection-control precautions, public-health notification and hantavirus testing [4,8,10].

Patients should also mention when symptoms started, whether they had fever, muscle pain, gastrointestinal symptoms, cough, chest tightness or shortness of breath, and whether they had close contact with anyone who was ill [6,8,10]. Because Andes virus symptoms may appear up to 42 days after exposure, travel history from the previous several weeks is important [8].

What Doctors Should Watch For

Clinicians should consider Andes virus infection when a patient has compatible symptoms and a relevant exposure history linked to the MV Hondius outbreak, South America travel, rodent exposure or close contact with a confirmed or suspected case [4,8,10]. Early symptoms may be non-specific, so the travel and contact history may be the most important clue [4,8,10].

The clinical pattern of fever, severe muscle aches, fatigue and gastrointestinal symptoms followed by cough, chest tightness or shortness of breath should raise concern for hantavirus pulmonary syndrome in the right exposure setting [8,10,13]. Oxygen saturation, chest imaging, blood tests and appropriate laboratory testing may help identify patients who are progressing toward severe disease [10,13].

Because deterioration can be rapid, suspected cases should be managed with caution and early specialist input [8,10,13]. Supportive care, infection-control precautions and communication with public-health authorities are central to management [1,6,10,15].

Frequently Asked Questions

Conclusion

The MV Hondius hantavirus outbreak is a rare but serious travel-associated event involving Andes virus, a hantavirus capable of causing severe pulmonary disease [1,2,3]. WHO reported 11 cases and 3 deaths as of 13 May 2026, while ECDC listed 8 confirmed cases, 2 probable cases and 1 inconclusive case [1,2]. The outbreak became internationally important because it combined severe illness, deaths, cruise travel, multi-country passenger movement and the rare possibility of close-contact human-to-human Andes virus transmission [1,2,6,8].

At the same time, official agencies continue to state that the risk to the wider public is low or extremely low [1,2,3]. The main concern is not casual public exposure, but relevant exposure among passengers, crew and close contacts [1,6,7,8]. Anyone connected to the outbreak who develops fever, severe body aches, gastrointestinal symptoms, cough, chest tightness or breathlessness should seek urgent medical care and clearly mention the MV Hondius, Andes virus exposure risk, South America travel or possible rodent exposure [4,8,10].

The most responsible message is awareness without panic. Andes virus is uncommon, but it can be dangerous when symptoms progress to hantavirus pulmonary syndrome [8,13]. Early recognition, accurate travel history, contact tracing, monitoring and timely hospital care remain the most important tools for protecting exposed individuals and preventing further spread [1,6,8,10,15].

References 

[1] World Health Organization

World Health Organization. (2026, May 13). Hantavirus cluster linked to cruise ship travel, multi-country. Disease Outbreak News. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON601

Reader brief: This is the most important primary reference for the article. Use it for the official WHO case count, deaths, case classification, risk assessment, source hypothesis, public-health response, monitoring advice, treatment limitations and WHO guidance. WHO reported 11 cases and 3 deaths as of 13 May 2026 and described the working hypothesis of land exposure before boarding followed by possible onboard human-to-human transmission.

[2] European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control. (2026, May 13). Andes hantavirus outbreak in cruise ship, 13 May 2026. https://www.ecdc.europa.eu/en/infectious-disease-topics/hantavirus-infection/surveillance-and-updates/andes-hantavirus-outbreak

Reader brief: Use this for the EU/EEA daily outbreak update, confirmed/probable/inconclusive case numbers, disembarkation status, risk level and ECDC case-definition language. ECDC states that Andes virus is the hantavirus associated with this outbreak and that the risk to the general EU/EEA population is very low.

[3] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026, May 12). Andes virus outbreak on a cruise ship: Current situation. https://www.cdc.gov/hantavirus/situation-summary/index.html

Reader brief: Use this for the CDC’s official current-situation summary, especially the statement that public and traveler risk remains extremely low, no U.S. cases had been confirmed from the outbreak at the time of update, and CDC was supporting repatriation and monitoring.

[4] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026, May 8). 2026 multi-country hantavirus cluster linked to cruise ship. Health Alert Network Health Advisory, HAN 00528. https://www.cdc.gov/han/php/notices/han00528.html

Reader brief: Use this for early outbreak chronology, route details, ship departure from Ushuaia, passenger/crew numbers, country spread and the CDC alert to clinicians. It is useful for the timeline and “what doctors should ask” sections.

[5] World Health Organization

World Health Organization. (2026, May 10). WHO technical note for the disembarkation and onward management of passengers and crew in the context of an Andes virus-associated cluster: MV Hondius cruise ship. https://www.who.int/publications/m/item/who-technical-note-for-the-disembarkation-and-onward-management-of-passengers-and-crew-in-the-context-of-an-andes-virus-associated-cluster-mv-hondius-cruise-ship

Reader brief: Use this for disembarkation, onward travel, port-health coordination and follow-up of passengers and crew. This is particularly important for the public-health logistics section.

[6] World Health Organization

World Health Organization. (2026, May 10). Management of contacts of Andes virus (ANDV) cases from the MV Hondius cruise ship. https://www.who.int/publications/m/item/management-of-contacts-of-andes-virus-%28andv%29-cases-fromthe-mv-hondius-cruise-ship

Reader brief: Use this for contact-risk classification, close-contact definitions, risk-based monitoring and management of exposed passengers. It supports the “high-risk vs low-risk contacts” section.

[7] UK Health Security Agency

UK Health Security Agency. (2026, May 6; updated May 13). UKHSA update on the hantavirus cruise ship outbreak. GOV.UK. https://www.gov.uk/government/news/ukhsa-update-on-the-hantavirus-cruise-ship-outbreak

Reader brief: Use this for UK repatriation, passenger assessment, testing, strict infection-control precautions and the 45-day isolation/monitoring approach used for UK passengers.

[8] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026, May 9). About Andes virus. https://www.cdc.gov/hantavirus/about/andesvirus.html

Reader brief: Use this for the basic Andes virus explainer: transmission, incubation period, symptoms, prevention, person-to-person risk and absence of a specific antiviral treatment or vaccine. CDC states that symptoms may appear 4 to 42 days after exposure.

[9] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026). Andes virus outbreak on a cruise ship: Frequently asked questions. https://www.cdc.gov/hantavirus/faq/index.html

Reader brief: Use this for FAQ answers about severity, close-contact transmission, testing, quarantine/monitoring and why this is not like COVID-19. CDC explains that close contact may include prolonged physical contact, prolonged enclosed-space exposure, kissing, sharing utensils or handling contaminated bedding.

[10] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026, May 8). Clinician brief: Hantavirus pulmonary syndrome (HPS). https://www.cdc.gov/hantavirus/hcp/clinical-overview/hps.html

Reader brief: Use this for clinical symptoms, diagnostic difficulty, differential diagnosis, testing methods, ICU care, oxygen support, ventilation, ECMO and poor outcomes when cardiopulmonary deterioration is not managed early.

[11] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2024, April 8). How to clean up after rodents. https://www.cdc.gov/healthy-pets/rodent-control/clean-up.html

Reader brief: Use this for the practical rodent-cleanup section. It supports advice not to sweep or vacuum droppings, to ventilate areas, wear gloves and wet contaminated material with disinfectant before disposal.

[12] Centers for Disease Control and Prevention

Centers for Disease Control and Prevention. (2026). Cruise ship travel. CDC Travelers’ Health. https://wwwnc.cdc.gov/travel/page/cruise-ship

Reader brief: Use this for general cruise-travel health advice, including reporting illness to the ship medical center and continuing routine cruise travel for the general public when risk is low.

[13] World Health Organization

World Health Organization. (2026, May 6). Hantavirus. https://www.who.int/news-room/fact-sheets/detail/hantavirus

Reader brief: Use this as the general WHO hantavirus fact sheet. It explains hantavirus types, rodent exposure, HCPS/HPS in the Americas, HFRS in Europe/Asia, diagnosis, prevention, safe cleaning, supportive care and lack of a specific treatment or vaccine.

[14] European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control. (2026, May 6). Hantavirus-associated cluster of illness on a cruise ship: ECDC assessment and recommendations. https://www.ecdc.europa.eu/en/publications-data/hantavirus-associated-cluster-illness-cruise-ship-ecdc-assessment-and

Reader brief: Use this for the early ECDC outbreak assessment, onboard exposure hypothesis, person-to-person transmission risk, EU/EEA risk assessment, infection-control advice, testing caveats and recommendation that symptomatic passengers be managed carefully.

[15] European Medicines Agency

European Medicines Agency. (2026, May 12). EMA actively monitoring cruise ship hantavirus outbreak. https://www.ema.europa.eu/en/news/ema-actively-monitoring-cruise-ship-hantavirus-outbreak

Reader brief: Use this for treatment/vaccine status, supportive-care reliance, EMA’s monitoring of possible medicines and the misinformation section. EMA states that no authorized antiviral treatment or vaccine is currently available and warns against misinformation linking hantavirus to COVID-19 vaccination.

[16] Pan American Health Organization / World Health Organization

Pan American Health Organization. (2025, December 19). Epidemiological alert: Hantavirus pulmonary syndrome in the Americas Region. https://www.paho.org/en/documents/epidemiological-alert-hantavirus-pulmonary-syndrome-americas-region-19-december-2025

Reader brief: Use this for regional South American context. It is useful for explaining why Andes virus and hantavirus pulmonary syndrome remain important public-health concerns in the Americas, especially in the Southern Cone.

[17] World Health Organization

World Health Organization. (2016). Handbook for management of public health events on board ships. https://www.who.int/publications-detail-redirect/handbook-for-management-of-public-health-events-on-board-ships

Reader brief: Use this for general shipboard public-health management, International Health Regulations context, port health measures and how public-health events on ships are assessed and managed.

[18] World Health Organization

World Health Organization. (2011). Guide to ship sanitation (3rd ed.). https://www.who.int/publications/i/item/9789241546690

Reader brief: Use this for ship sanitation, pest control, food/water hygiene, storage areas, environmental control and prevention of infectious hazards on vessels. This should be used as background support rather than as proof of this specific outbreak source.

[19] Ferrés et al., 2024

Ferrés, M., Martínez-Valdebenito, C., Henríquez, C., et al. (2024). Viral shedding and viraemia of Andes virus during acute hantavirus infection: A prospective study. The Lancet Infectious Diseases, 24(7), 775–782. https://doi.org/10.1016/S1473-3099(24)00142-7

Reader brief: Use this modern clinical study for the “secret science” section on viral shedding. The study supports discussion of Andes virus detection in body fluids and explains why saliva, respiratory secretions and close-contact exposure matter in infection-control planning.

[20] Martínez et al., 2020

Martínez, V. P., Di Paola, N., Alonso, D. O., et al. (2020). “Super-spreaders” and person-to-person transmission of Andes virus in Argentina. The New England Journal of Medicine, 383(23), 2230–2241. https://doi.org/10.1056/NEJMoa2009040

Reader brief: Use this as a key peer-reviewed reference for person-to-person Andes virus transmission. It documents an Argentine outbreak and supports the article’s explanation that Andes virus is unusual among hantaviruses because close-contact human transmission has been documented.

[21] Ferrés et al., 2007

Ferrés, M., Vial, P., Marco, C., Yáñez, L., Godoy, P., Castillo, C., Hjelle, B., Delgado, I., Lee, S. J., & Mertz, G. J. (2007). Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. The Journal of Infectious Diseases, 195(11), 1563–1571. https://doi.org/10.1086/516786

Reader brief: Use this for household-contact and intimate-contact risk. The study is especially useful for explaining why close contacts, sex partners and people with prolonged household exposure may require monitoring.

[22] Alonso et al., 2020

Alonso, D. O., Pérez-Sautu, U., Bellomo, C. M., Prieto, K., Iglesias, A., Coelho, R., Periolo, N., Domenech, I., Talmon, G., Hansen, R., Palacios, G., & Martínez, V. P. (2020). Person-to-person transmission of Andes virus in hantavirus pulmonary syndrome, Argentina, 2014. Emerging Infectious Diseases, 26(4), 756–759. https://doi.org/10.3201/eid2604.190799

Reader brief: Use this as additional scientific support for person-to-person transmission. It used sequencing evidence to support Andes virus transmission between people in a small Argentine cluster.

[23] Vial et al., 2023

Vial, P. A., Ferrés, M., Vial, C., Klingström, J., Ahlm, C., López, R., Le Corre, N., & Mertz, G. J. (2023). Hantavirus in humans: A review of clinical aspects and management. The Lancet Infectious Diseases, 23(9), e371–e382. https://doi.org/10.1016/S1473-3099(23)00128-7

Reader brief: Use this review for medical background, clinical presentation, HPS/HCPS, HFRS, pathophysiology, management and Andes virus’s unique transmission features. It is a strong review source for doctors and medically aware readers.

[24] Dietl et al., 2008

Dietl, C. A., Wernly, J. A., Pett, S. B., Yassin, S. F., Sterling, J. P., Dragan, R., Milligan, K., & Crowley, M. R. (2008). Extracorporeal membrane oxygenation support improves survival of patients with severe hantavirus cardiopulmonary syndrome. The Journal of Thoracic and Cardiovascular Surgery, 135(3), 579–584. https://doi.org/10.1016/j.jtcvs.2007.11.020

Reader brief: Use this for the ICU/ECMO section. It supports the statement that selected severe HCPS patients may benefit from specialized extracorporeal support when respiratory and circulatory failure are refractory to conventional care.

[25] Wernly et al., 2011

Wernly, J. A., Dietl, C. A., Tabe, C. E., Pett, S. B., Crandall, C., Milligan, K., & Crowley, M. R. (2011). Extracorporeal membrane oxygenation support improves survival of patients with hantavirus cardiopulmonary syndrome refractory to medical treatment. European Journal of Cardio-Thoracic Surgery, 40(6), 1334–1340. https://doi.org/10.1016/j.ejcts.2011.01.089

Reader brief: Use this as a second ECMO/critical-care reference. It helps support the clinical message that severe hantavirus cardiopulmonary syndrome needs rapid referral to advanced critical-care facilities.

[26] Toledo et al., 2022

Toledo, J., Haby, M. M., Reveiz, L., Sosa Leon, L., Angerami, R., & Aldighieri, S. (2022). Evidence for human-to-human transmission of hantavirus: A systematic review. The Journal of Infectious Diseases, 226(8), 1362–1371. https://doi.org/10.1093/infdis/jiab461

Reader brief: Use this carefully for a balanced evidence discussion. It reviews human-to-human transmission evidence and helps prevent overstatement. In the article, it can be used to say that Andes virus transmission between humans has been documented, but the strength and pattern of transmission must be interpreted cautiously.

[27] Oude Munnink et al., 2026

Oude Munnink, B., Huber, M., Cordey, S., Diagne, M. M., Weyer, J., et al. (2026, May 10). Preliminary analysis of Orthohantavirus andesense virus sequences from a cruise-ship related cluster, May 2026. Virological.org. https://virological.org/t/preliminary-analysis-of-orthohantavirus-andesense-virus-sequences-from-a-cruise-ship-related-cluster-may-2026/1029

Reader brief: Use this only as an optional “advanced science” or genomic-analysis note. It is a preliminary, non-peer-reviewed sequence analysis, so the article should describe it cautiously and not use it as the main authority for public-health claims.

[28] Agniveśa, Caraka and Dṛḍhabala

Agniveśa. (Classical text; revised by Caraka and Dṛḍhabala). Caraka Saṃhitā: Vimāna Sthāna, Chapter 3, Janapadodhvaṃsanīya Vimāna. In Caraka Saṃhitā online edition. https://carakasamhitaonline.com/index.php/Janapadodhvansaniya_Vimana

Reader brief: Use this for the Ayurvedic perspective section. This chapter discusses Janapadodhwamsa, traditionally understood as widespread community illness influenced by vitiation of air, water, land and seasonal/environmental factors. It should be presented as a classical public-health concept, not as proof of hantavirus virology or as a substitute for emergency care.

[29] Bhavana and Shreevathsa, 2014

Bhavana, K. R., & Shreevathsa. (2014). Medical geography in Charaka Samhita. AYU. https://pmc.ncbi.nlm.nih.gov/articles/PMC4492020/

Reader brief: Use this as a modern Ayurvedic interpretive reference for geography, environment and community health concepts in Charaka Samhita. It can support a respectful bridge between classical Ayurveda and modern public-health thinking, while keeping acute hantavirus management firmly within emergency medicine.